These terms and conditions govern your use of the website alphaminr.com and its related
services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr,
(“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms
include the provisions in this document as well as those in the Privacy Policy. These terms may
be modified at any time.
Subscription
Your subscription will be on a month to month basis and automatically renew every month. You may
terminate your subscription at any time through your account.
Fees
We will provide you with advance notice of any change in fees.
Usage
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Limitation of Liability
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The
service is provided “As is”. The materials and information accessible through the Service are
solely for informational purposes. While we strive to provide good information and data, we make
no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO
YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY
OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR
(2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE
CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR
CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision
shall not affect the validity or enforceability of the remaining provisions herein.
Privacy Policy
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal
information when we provide our service (“Service”). This Privacy Policy explains how
information is collected about you either directly or indirectly. By using our service, you
acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy
Policy, please do not use our Service. You should contact us if you have questions about it. We
may modify this Privacy Policy periodically.
Personal Information
When you register for our Service, we collect information from you such as your name, email
address and credit card information.
Usage
Like many other websites we use “cookies”, which are small text files that are stored on your
computer or other device that record your preferences and actions, including how you use the
website. You can set your browser or device to refuse all cookies or to alert you when a cookie
is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not
function properly. We collect information when you use our Service. This includes which pages
you visit.
Sharing of Personal Information
We use Google Analytics and we use Stripe for payment processing. We will not share the
information we collect with third parties for promotional purposes.
We may share personal information with law enforcement as required or permitted by law.
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
529 Pleasant Street
Attleboro
,
Massachusetts
,
02703
,
United States
(Address of principal executive offices, including zip code)
+1
(
508
)
236 3800
(Registrant's telephone number, including area code)
Not applicable
(Former name, former address and former fiscal year, if changed since last report)
_____________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of exchange on which registered
Ordinary Shares - nominal value €0.01 per share
ST
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
☐
No
☒
As of July 16, 2025,
145,639,006
ordinary shares were outstanding.
Accounts receivable, net of allowances of $
19,338
and $
20,524
as of June 30, 2025 and December 31, 2024, respectively
785,192
660,180
Inventories
636,021
614,455
Prepaid expenses and other current assets
157,030
158,934
Total current assets
2,240,020
2,027,239
Property, plant and equipment, net
806,003
821,653
Goodwill
3,383,845
3,383,800
Other intangible assets, net of accumulated amortization of $
2,562,191
and $
2,561,335
as of June 30, 2025 and December 31, 2024, respectively
453,582
492,878
Deferred income tax assets
279,301
288,189
Other assets
107,321
129,505
Total assets
$
7,270,072
$
7,143,264
Liabilities and shareholders' equity
Current liabilities:
Current portion of long-term debt and finance lease obligations
$
2,156
$
2,414
Accounts payable
469,863
362,186
Income taxes payable
41,246
29,417
Accrued expenses and other current liabilities
313,847
317,341
Total current liabilities
827,112
711,358
Deferred income tax liabilities
241,090
235,689
Pension and other post-retirement benefit obligations
31,298
27,910
Finance lease obligations, less current portion
19,968
20,984
Long-term debt, net
3,178,457
3,176,098
Other long-term liabilities
91,936
80,782
Total liabilities
4,389,861
4,252,821
Commitments and contingencies (Note 11)
Shareholders’ equity:
Ordinary shares, €
0.01
nominal value per share,
177,069
shares authorized, and
176,868
and
176,541
shares issued as of June 30, 2025 and December 31, 2024, respectively
2,260
2,257
Treasury shares, at cost,
31,230
and
26,994
shares as of June 30, 2025 and December 31, 2024, respectively
(
1,402,651
)
(
1,282,051
)
Additional paid-in capital
1,883,944
1,872,577
Retained earnings
2,431,819
2,340,203
Accumulated other comprehensive loss
(
35,161
)
(
42,543
)
Total shareholders' equity
2,880,211
2,890,443
Total liabilities and shareholders' equity
$
7,270,072
$
7,143,264
The accompanying notes are an integral part of these condensed consolidated financial statements.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements reflect the financial position, results of operations, comprehensive income, cash flows, and changes in shareholders' equity of Sensata Technologies Holding plc, a public limited company incorporated under the laws of England and Wales, and its consolidated subsidiaries, collectively referred to as the "Company," "Sensata," "we," "our," or "us."
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP") for interim financial information and the instructions to Form 10-Q. Accordingly, these interim financial statements do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements. The accompanying interim financial information reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the interim period results. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the U.S. Securities and Exchange Commission (the "SEC") on February 28, 2025 (the "2024 Annual Report").
We present financial information for
two
reportable segments, Performance Sensing ("PS") and Sensing Solutions ("SS"). Additionally, our business strategy involves leveraging new and emerging technologies, which complement our existing product offerings, and we refer to these trends collectively as “megatrends.” Our operating segments’ performance is primarily evaluated based on segment operating income. In the three months ended March 31, 2025, we realigned the definition of segment operating income to include megatrend costs, which were previously excluded from segment operating income and included in corporate and other costs. Prior period amounts in this Quarterly Report on Form 10-Q have been recast to reflect this realignment and to conform to current year presentation. Refer to
Note 15: Segment Reporting
for additional information.
All U.S. dollar ("USD") and share amounts presented, except per share amounts, are stated in thousands, unless otherwise indicated. Certain prior period amounts have been recast to conform to current year presentation.
2.
New Accounting Standards
In December 2023, the FASB issued Accounting Standards Update ("ASU") No. 2023-09,
Income taxes (Topic 740): Improvements to Income Tax Disclosures
, which requires (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) disclosure of income taxes paid disaggregated by jurisdiction. ASU No. 2023-09 also includes certain other updates to improve the effectiveness of income tax disclosures. ASU No. 2023-09 is effective for annual periods beginning after December 15, 2024, and should be applied prospectively, with retrospective application also a permitted option. The Company is currently evaluating the impact that the adoption of ASU No. 2023-09 will have on its consolidated financial statements and disclosures.
In November 2024, the FASB issued ASU No. 2024-03
Income Statement (Topic 220): Reporting Comprehensive Income
, which
requires additional disclosure of the nature of expenses included in the income statement as well as disclosures about specific types of expenses included in the expense captions presented in the income statement
.
ASU No. 2024-03 does not change or remove current expense presentation requirements within the Consolidated Statements of Operations. However, the update requires disclosure, on an annual and interim basis, of disaggregated information about certain income statement expense line items within the notes to the consolidated financial statements. ASU No. 2024-03 is effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact that the adoption of ASU No. 2024-03 will have on its consolidated financial statements and disclosures.
The following table presents net revenue disaggregated by end market for the three and six months ended June 30, 2025 and 2024:
For the three months ended June 30, 2025
For the three months ended June 30, 2024
PS
SS
Other
Total
PS
SS
Other
Total
Automotive
$
495,542
$
31,742
$
—
$
527,284
$
543,158
$
32,389
$
—
$
575,547
HVOR
156,683
6,801
—
163,484
180,763
7,530
—
188,293
Industrial
—
161,817
—
161,817
—
141,541
—
141,541
HVAC
—
42,970
—
42,970
—
41,240
—
41,240
Aerospace
—
47,829
—
47,829
—
45,371
—
45,371
Other
—
—
—
—
—
—
43,543
43,543
Total
$
652,225
$
291,159
$
—
$
943,384
$
723,921
$
268,071
$
43,543
$
1,035,535
For the six months ended June 30, 2025
For the six months ended June 30, 2024
PS
SS
Other
Total
PS
SS
Other
Total
Automotive
$
996,496
$
62,248
$
—
$
1,058,744
$
1,073,782
$
64,797
$
—
$
1,138,579
HVOR
306,145
12,403
—
318,548
363,457
14,388
—
377,845
Industrial
—
300,385
—
300,385
—
275,890
—
275,890
HVAC
—
81,884
—
81,884
—
79,311
—
79,311
Aerospace
—
95,078
—
95,078
—
91,524
—
91,524
Other
—
—
—
—
—
—
79,095
79,095
Total
$
1,302,641
$
551,998
$
—
$
1,854,639
$
1,437,239
$
525,910
$
79,095
$
2,042,244
4.
Share-Based Payment Plans
The following table presents the components of non-cash compensation expense related to our equity awards for the three and six months ended June 30, 2025 and 2024:
For the three months ended
For the six months ended
June 30, 2025
June 30, 2024
June 30, 2025
June 30, 2024
Stock options
$
—
$
569
$
—
$
569
Restricted securities
4,516
3,242
11,367
11,375
Share-based compensation expense
$
4,516
$
3,811
$
11,367
$
11,944
Equity Awards
We granted the following restricted stock units ("RSUs" and each, an "RSU") and performance-based restricted stock units ("PRSUs" and each, a "PRSU") during the six months ended June 30, 2025:
Awards Granted To:
Type of Award
Number of Units Granted (in thousands)
Weighted Average Grant Date Fair Value
Directors, various executives, and employees
RSU
(1)
140
$
26.23
Various executives and employees
RSU
(2)
904
$
24.66
Various executives and employees
PRSU
(3)
248
$
24.23
Various executives and employees
PRSU
(4)
248
$
25.64
____________________________________
(1)
These awards cliff vest up to
one year
from the grant date (various dates between January 2026 and June 2026).
(2)
These RSUs vest ratably over
three years
, one-third per year beginning on the first anniversary of the grant date. These RSUs will fully vest on various dates between January 2028 and June 2028.
(3)
These
PRSUs vest in April 2028. The number of units that ultimately vest will be between
0
% and
150
% and is dependent on the achievement of certain performance criteria.
(4)
These awards include certain PRSUs with market performance conditions that will be evaluated relative to the performance of certain peers as defined in the award agreement. The number of units that ultimately vest (in April 2028) will be from
0
% to
150
%, depending on achievement of these performance criteria. Total grant date value of these PRSUs is approximately $
6.4
million and was valued using the Monte Carlo method.
5.
Restructuring and Other Charges, Net
2H 2024 Plan
In the year ended December 31, 2024, we committed to a plan to reorganize our business (the “2H 2024 Plan”). The 2H 2024 Plan, consisting of involuntary reductions-in-force, site closures, and other cost-savings initiatives, was commenced to adjust our cost structure and business activities to better align with weaker market demand and continued economic uncertainty in many of our end markets and to take active measures to accelerate our margin recovery.
The reductions-in-force, which are subject to the laws and regulations of the countries in which the actions were executed or planned, are expected to impact approximately
240
positions. Over the life of the 2H 2024 Plan, we expect to incur restructuring charges of between $
15.5
million and $
16.5
million, primarily related to reductions-in-force. The majority of the actions under the 2H 2024 Plan are expected to be completed on or before December 31, 2025. We expect to settle these charges with cash on hand.
Q3 2023 Plan
In the year ended December 31, 2023, we committed to a plan to reorganize our business (the “Q3 2023 Plan”). The Q3 2023 Plan, consisting of voluntary and involuntary reductions-in-force, site closures, and other cost-savings initiatives, was commenced to adjust our cost structure and business activities.
The reductions-in-force, which are subject to the laws and regulations of the countries in which the actions were executed or planned, impacted
505
positions. Over the life of the Q3 2023 Plan, we expect to incur restructuring charges of between $
26.7
million and $
27.6
million, primarily related to reductions-in-force. The majority of the actions under the Q3 2023 Plan are expected to be completed on or before December 31, 2025. We expect to settle these charges with cash on hand.
Summary
The following table presents the components of restructuring and other charges, net for the three and six months ended June 30, 2025, and 2024:
For the three months ended
For the six months ended
June 30, 2025
June 30, 2024
June 30, 2025
June 30, 2024
2H 2024 Plan, net
$
1,307
$
—
$
3,761
$
—
Q3 2023 Plan, net
1,884
(
303
)
2,802
295
Other restructuring and other charges, net
Severance charges, net
1,262
2,464
1,182
2,455
Facility and other exit costs
—
32
—
200
Loss on sale of business
—
—
4,420
—
Acquisition-related compensation arrangements
(1)
—
955
—
1,910
Other
2,159
343
1,427
(
587
)
Restructuring and other charges, net
$
6,612
$
3,491
$
13,592
$
4,273
___________________________________
(1)
Acquisition-related compensation arrangements consist of incentive compensation to previous owners of companies we have acquired. Payment is generally tied to technical and/or financial targets set at the time of acquisition.
The following table presents a rollforward of our severance liability, which is primarily related to the 2H 2024 Plan, for the six months ended June 30, 2025:
Total
Balance as of December 31, 2024
6,087
Charges, net of reversals
1,958
Payments
(
4,308
)
Foreign currency remeasurement
265
Balance as of June 30, 2025
$
4,002
The severance liability as of June 30, 2025 and December 31, 2024 was entirely recorded in accrued expenses and other current liabilities on our condensed consolidated balance sheets.
Other
In the three months ended June 30, 2024, we initiated certain actions related to restructuring of our IT operations and product lifecycle management including product line discontinuations, which, for the three and six months ended June 30, 2024, resulted in total costs of $
15.9
million, including severance, contract termination costs, and inventory charges. Of the costs recognized, $
13.2
million was included within cost of revenue and the remainder was included within restructuring and other charges, net.
6.
Other, Net
The following table presents the components of other, net for the three and six months ended June 30, 2025 and 2024:
For the three months ended
For the six months ended
June 30, 2025
June 30, 2024
June 30, 2025
June 30, 2024
Currency remeasurement gain/(loss) on net monetary assets
$
399
$
3,398
$
(
60
)
$
4,429
Loss on foreign currency forward contracts
(
2,519
)
(
1,837
)
(
4,095
)
(
1,157
)
Gain on commodity forward contracts
1,593
4,977
6,012
6,076
Gain/(loss) on equity investments, net
(1)
1,012
(
1,019
)
1,027
(
14,306
)
Net periodic benefit cost, excluding service cost
(
630
)
(
820
)
(
1,157
)
(
1,661
)
Other
1,075
(
602
)
1,331
(
828
)
Other, net
$
930
$
4,097
$
3,058
$
(
7,447
)
___________________________________
(1)
The six months ended June 30, 2024 primarily includes a loss on an equity investment that does not have a readily determinable fair value for which we use the measurement alternative prescribed in FASB ASC Topic 321,
Investments—Equity Securities
. Refer to
Note 13: Fair Value Measures
for additional information.
7.
Income Taxes
The following table presents the provision for income taxes for the three and six months ended June 30, 2025 and 2024:
For the three months ended
For the six months ended
June 30, 2025
June 30, 2024
June 30, 2025
June 30, 2024
Provision for income taxes
$
45,112
$
27,280
$
65,834
$
49,850
The provision for income taxes consists of (1) current tax expense, which relates primarily to our profitable operations in tax jurisdictions with limited or no net operating loss carryforwards and withholding taxes related to management fees, royalties, and the repatriation of foreign earnings; and (2) deferred tax expense (or benefit), which represents adjustments in book-to-tax basis differences primarily related to (a) book versus tax basis in intangible assets, (b) changes in net operating loss carryforwards and tax credits, and (c) changes in withholding taxes on unremitted earnings.
In July 2025, the U.S. enacted the One Big Beautiful Bill Act, which introduced significant changes to the federal tax code such as the permanent extension of select Tax Cuts and Jobs Act measures, updates to international tax rules, and the reinstatement of favorable business tax treatments. The One Big Beautiful Bill Act includes multiple effective dates, with some provisions
retroactive to January 1, 2025, and others will become effective through 2027. The Company is currently evaluating the impact on our consolidated financial statements and disclosures.
8.
Net Income per Share
Basic and diluted net income per share are calculated by dividing net income by the number of basic and diluted weighted-average ordinary shares outstanding during the period.
For the three and six months ended June 30, 2025 and 2024 the weighted-average ordinary shares outstanding used to calculate basic and diluted net income per share were as follows:
Net income and net income per share are presented in the condensed consolidated statements of operations.
Certain potential ordinary shares were excluded from our calculation of diluted weighted-average ordinary shares outstanding because either they would have had an anti-dilutive effect on net income per share or they related to equity awards that were contingently issuable for which the contingency had not been satisfied.
These potential ordinary shares were as follows:
For the three months ended
For the six months ended
June 30, 2025
June 30, 2024
June 30, 2025
June 30, 2024
Anti-dilutive shares excluded
1,362
1,239
1,250
1,501
Contingently issuable shares excluded
1,014
929
854
995
9.
Inventories
The following table presents the components of inventories as of June 30, 2025 and December 31, 2024:
The following table presents the components of long-term debt, net and finance lease obligations as of June 30, 2025 and December 31, 2024:
Maturity Date
June 30,
2025
December 31,
2024
4.0
% Senior Notes
April 15, 2029
1,000,000
1,000,000
4.375
% Senior Notes
February 15, 2030
450,000
450,000
5.875
% Senior Notes
September 1, 2030
500,000
500,000
3.75
% Senior Notes
February 15, 2031
750,000
750,000
6.625
% Senior Notes
July 15, 2032
500,000
500,000
Plus: debt premium, net of discount
880
997
Less: deferred financing costs
(
22,423
)
(
24,899
)
Long-term debt, net
$
3,178,457
$
3,176,098
Finance lease obligations
$
22,124
$
23,398
Less: current portion
(
2,156
)
(
2,414
)
Finance lease obligations, less current portion
$
19,968
$
20,984
Our indebtedness as of June 30, 2025 and December 31, 2024 consists of various tranches of senior unsecured notes as shown in the table above. We also have secured credit facilities (the "Senior Secured Credit Facilities") which provide for our $
750.0
million revolving credit facility (the "Revolving Credit Facility") and incremental availability under which additional debt can be issued. Refer to
Note 14: Debt
of our 2024 Annual Report for additional information related to our indebtedness.
Revolving Credit Facility
As of June 30, 2025, we had $
745.8
million available under the Revolving Credit Facility, net of $
4.2
million of obligations in respect of outstanding letters of credit issued thereunder. Outstanding letters of credit are issued primarily for the benefit of certain operating activities. As of June 30, 2025,
no
amounts had been drawn against these outstanding letters of credit.
Accrued Interest
Accrued interest associated with our outstanding debt is included as a component of accrued expenses and other current liabilities in the condensed consolidated balance sheets. As of June 30, 2025 and December 31, 2024, accrued interest totaled $
51.6
million and $
55.2
million, respectively.
11.
Commitments and Contingencies
We are regularly involved in a number of claims and litigation matters that arise in the ordinary course of business. Although it is not feasible to predict the outcome of these matters, based upon our experience and current information known to us, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our results of operations, financial condition, and/or cash flows.
Cybersecurity Incident
In April 2025, we experienced a ransomware incident that encrypted certain devices in our network. The incident temporarily impacted our operations, but the incident did not have a material impact on the Company’s financial results and operations for the three and six months ended June 30, 2025.
12.
Shareholders' Equity
Purchase of Noncontrolling Interest in Joint Venture
In February 2024, we purchased the remaining
50
% interest in our joint venture with Dongguan Churod Electronics Co., Ltd. for approximately $
79.4
million. Prior to the transaction, we had been consolidating the joint venture. The purchase of the
50
% non-controlling interest was accounted for as an equity transaction. No gain or loss was recognized in the condensed consolidated statements of operations. The difference between the fair value of the consideration paid and the amount by which the non-controlling interest was adjusted was recognized as a reduction of additional paid in capital recorded in equity.
In the three and six months ended June 30, 2025, we paid aggregate cash dividends of $
17.6
million and $
35.5
million, respectively, compared to $
18.1
million and $
36.1
million in the three and six months ended June 30, 2024, respectively. In July 2025, we announced that our Board of Directors approved a quarterly dividend of $
0.12
per share, payable in August 2025 to shareholders of record as of August 13, 2025.
Treasury Shares
From time to time, our Board of Directors has authorized various share repurchase programs, which may be modified or terminated by the Board at any time. Under these programs, we may repurchase ordinary shares at such times and in amounts to be determined by our management, based on market conditions, legal requirements, and other corporate considerations, on the open market or in privately negotiated transactions, provided that such transactions were completed pursuant to an agreement and with a third party approved by our shareholders at the annual general meeting. Ordinary shares repurchased by us are recognized, measured at cost, and presented as treasury shares on our consolidated balance sheets, resulting in a reduction of shareholders' equity. In September 2023, our Board of Directors authorized a $
500.0
million ordinary share repurchase program (the “September 2023 Program”), which became effective on October 1, 2023.
In the three months ended June 30, 2025, we repurchased
0.7
million ordinary shares for $
20.1
million, under the September 2023 Program. In the three months ended June 30, 2024, we did
not
purchase any shares under our share repurchase program. In the six months ended June 30, 2025 and 2024, we repurchased
4.2
million and
0.3
million ordinary shares, respectively, for $
120.6
million and $
10.1
million, respectively. All share repurchases in the three and six months ended June 30, 2025 and 2024 were made under the September 2023 Program. As of June 30, 2025, $
282.4
million remained available for repurchase under the September 2023 Program.
Accumulated Other Comprehensive Loss
The following table presents the components of accumulated other comprehensive loss for the six months ended June 30, 2025:
Cash Flow Hedges
Defined Benefit and Retiree Healthcare Plans
Cumulative Translation Adjustment
Accumulated Other Comprehensive Loss
Balance as of December 31, 2024
$
(
7,913
)
$
(
11,690
)
$
(
22,940
)
$
(
42,543
)
Other comprehensive (loss)/income before reclassifications, net of tax
(
9,224
)
—
13,677
4,453
Reclassifications from accumulated other comprehensive loss, net of tax
The following table presents the amounts reclassified from accumulated other comprehensive loss for the three and six months ended June 30, 2025 and 2024:
For the three months ended June 30,
For the six months ended June 30,
Affected Line in Condensed Consolidated Statements of Operations
Component
2025
2024
2025
2024
Derivative instruments designated and qualifying as cash flow hedges:
Foreign currency forward contracts
$
764
$
(
762
)
$
(
4,263
)
$
(
870
)
Net revenue
(1)
Foreign currency forward contracts
4,417
(
8,485
)
7,531
(
15,839
)
Cost of revenue
(1)
Total, before taxes
5,181
(
9,247
)
3,268
(
16,709
)
Income before taxes
Income tax effect
(
1,336
)
2,386
(
843
)
4,311
Provision for income taxes
Total, net of taxes
$
3,845
$
(
6,861
)
$
2,425
$
(
12,398
)
Net income
Defined benefit and retiree healthcare plans
Defined benefit and retiree healthcare plans
$
19
$
271
$
10
$
567
Other, net
Defined benefit and retiree healthcare plans
—
—
721
—
Restructuring and other charges, net
Total, before taxes
19
271
731
567
Income before taxes
Income tax effect
(
9
)
(
63
)
(
227
)
(
132
)
Provision for income taxes
Total, net of taxes
$
10
$
208
$
504
$
435
Net income
___________________________________
(1)
Refer to
Note 14: Derivative Instruments and Hedging Activities
for additional information regarding amounts to be reclassified from accumulated other comprehensive loss in future periods.
13.
Fair Value Measures
Measured on a Recurring Basis
The fair values of our assets and liabilities measured at fair value on a recurring basis as of June 30, 2025 and December 31, 2024 are shown in the below table.
June 30,
2025
December 31,
2024
Assets
Cash equivalents (Level 1)
$
368,667
$
243,640
Foreign currency forward contracts (Level 2)
12,423
19,110
Commodity forward contracts (Level 2)
4,288
1,486
Total
$
385,378
$
264,236
Liabilities
Foreign currency forward contracts (Level 2)
$
30,333
$
27,648
Commodity forward contracts (Level 2)
193
1,262
Total
$
30,526
$
28,910
Refer to
Note 14: Derivative Instruments and Hedging Activities
for additional information regarding our forward contracts. Cash equivalents consist of U.S. Government Treasury money market funds and are classified as Level 1 as they are exchange traded in an active market.
The following table presents the carrying values and fair values of financial instruments not recorded at fair value in the condensed consolidated balance sheets as of June 30, 2025 and December 31, 2024. All fair value measures presented are categorized in Level 2 of the fair value hierarchy.
June 30, 2025
December 31, 2024
Carrying Value
(1)
Fair Value
Carrying Value
(1)
Fair Value
Liabilities
4.0
% Senior Notes
$
1,000,000
$
951,520
$
1,000,000
$
915,000
4.375
% Senior Notes
$
450,000
$
429,944
$
450,000
$
410,625
5.875
% Senior Notes
$
500,000
$
501,200
$
500,000
$
485,000
3.75
% Senior Notes
$
750,000
$
685,260
$
750,000
$
652,500
6.625
% Senior Notes
$
500,000
$
515,125
$
500,000
$
497,500
___________________________________
(1)
Excluding any related debt discounts, premiums, and deferred financing costs.
In addition to the above, we hold certain equity investments that do not have readily determinable fair values for which we use the measurement alternative prescribed in FASB ASC Topic 321. Such investments are measured at cost, less any impairment, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer. As of June 30, 2025 and December 31, 2024, we held equity investments under the measurement alternative of $
7.3
million and $
6.1
million, respectively, which are presented in other assets in the condensed consolidated balance sheets.
14.
Derivative Instruments and Hedging Activities
Foreign Currency Derivatives
As of June 30, 2025, we had the following outstanding foreign currency forward contracts, which had the below hedge accounting designation in accordance with FASB ASC Topic 815,
Derivatives and Hedging
:
Notional
(in millions)
Effective Date(s)
Maturity Date(s)
Index (Exchange Rates)
Weighted-Average Strike Rate
Hedge
Designation
(1)
342.5
EUR
Various from July 2023 to June 2025
Various from July 2025 to June 2027
Euro ("EUR") to USD
1.11
USD
Cash flow hedge
3,470.5
MXN
Various from July 2023 to June 2025
Various from July 2025 to June 2027
USD to Mexican Peso ("MXN")
20.25
MXN
Cash flow hedge
58.4
GBP
Various from July 2023 to June 2025
Various from July 2025 to June 2027
British Pound Sterling ("GBP") to USD
1.28
USD
Cash flow hedge
Notional
(in millions)
Effective Date(s)
Maturity Date(s)
Index (Exchange Rates)
Weighted-Average Strike Rate
Hedge
Designation
(1)
58.2
EUR
June 26, 2025
July 31, 2025
EUR to USD
1.17
USD
Not designated
153.4
USD
Various from March 2024 to May 2024
Various from July 2025 to May 2026
USD to Chinese Renminbi ("CNY")
6.98
CNY
Not designated
1,071.4
CNY
Various September 2024
Various from July 2025 to May 2026
USD to CNY
6.80
CNY
Not designated
27,819.0
KRW
Various from August 2023 to September 2024
Various from July 2025 to July 2026
USD to Korean Won ("KRW")
1,312.75
KRW
Not designated
111.2
MXN
June 26, 2025
July 31, 2025
USD to MXN
18.95
MXN
Not designated
___________________________________
(1)
Derivative financial instruments not designated as hedges are used to manage our exposure to currency exchange rate risk. They are intended to preserve economic value, and they are not used for trading or speculative purposes.
As of June 30, 2025, we estimate that $
17.7
million of net losses will be reclassified from accumulated other comprehensive loss to earnings during the twelve-month period ending June 30, 2026.
Commodity Risk Derivatives
As of June 30, 2025, we had the following outstanding commodity forward contracts, none of which were designated for hedge accounting treatment:
Commodity
Notional
Remaining Contracted Periods
Weighted-Average Strike Price Per Unit
Silver
649,527
troy oz.
July 2025 to June 2027
$
31.53
Copper
5,131,320
pounds
July 2025 to June 2027
$
4.30
Financial Instrument Presentation
The following table presents the fair values of our derivative financial instruments and their classification in the condensed consolidated balance sheets as of June 30, 2025 and December 31, 2024:
Asset Derivatives
Liability Derivatives
Balance Sheet Location
June 30,
2025
December 31,
2024
Balance Sheet Location
June 30,
2025
December 31,
2024
Derivatives designated as hedging instruments
Foreign currency forward contracts
Prepaid expenses and other current assets
$
8,252
$
15,717
Accrued expenses and other current liabilities
$
19,757
$
17,018
Foreign currency forward contracts
Other assets
4,162
2,936
Other long-term liabilities
6,481
4,042
Total
$
12,414
$
18,653
$
26,238
$
21,060
Derivatives not designated as hedging instruments
Commodity forward contracts
Prepaid expenses and other current assets
$
3,432
$
1,413
Accrued expenses and other current liabilities
$
174
$
902
Commodity forward contracts
Other assets
856
73
Other long-term liabilities
19
360
Foreign currency forward contracts
Prepaid expenses and other current assets
2,335
457
Accrued expenses and other current liabilities
6,419
4,828
Foreign currency forward contracts
Other assets
3
—
Other long-term liabilities
4
1,760
Total
$
6,626
$
1,943
$
6,616
$
7,850
These fair value measurements were all categorized within Level 2 of the fair value hierarchy.
The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income for the three months ended June 30, 2025 and 2024:
Derivatives designated as
hedging instruments
Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive Income/(Loss)
Location of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income
Amount of Net (Loss)/Gain Reclassified from Accumulated Other Comprehensive Loss into Net Income
The following tables present the effect of our derivative financial instruments on the condensed consolidated statements of operations and the condensed consolidated statements of comprehensive income for the six months ended June 30, 2025 and 2024:
Derivatives designated as
hedging instruments
Amount of Deferred (Loss)/Gain Recognized in Other Comprehensive Income/(Loss)
Location of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income
Amount of Net Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Net Income
2025
2024
2025
2024
Foreign currency forward contracts
$
(
39,084
)
$
16,640
Net revenue
$
4,263
$
870
Foreign currency forward contracts
$
26,654
$
(
7,455
)
Cost of revenue
$
(
7,531
)
$
15,839
Derivatives not designated as
hedging instruments
Amount of Gain/(Loss) Recognized in Net Income
Location of Gain/(Loss) Recognized in Net Income
2025
2024
Commodity forward contracts
$
6,012
$
6,076
Other, net
Foreign currency forward contracts
$
(
4,095
)
$
(
1,157
)
Other, net
Credit Risk Related Contingent Features
We have agreements with our derivative counterparties that contain a provision whereby if we default on our indebtedness and repayment of the indebtedness has been accelerated by the lender, then we could also be declared in default on our derivative obligations.
As of June 30, 2025, the termination value of outstanding derivatives in a liability position, excluding any adjustment for non-performance risk, was $
33.0
million. As of June 30, 2025, we had
no
t posted any cash collateral related to these agreements. If we breach any of the default provisions on any of our indebtedness as described above, we could be required to settle our obligations under the derivative agreements at their termination values.
15.
Segment Reporting
We present financial information for
two
reportable segments, Performance Sensing and Sensing Solutions. Our segments are businesses that we manage as components of an enterprise, for which separate financial information is evaluated regularly by our chief operating decision maker ("CODM"), who is our chief executive officer, in deciding how to allocate resources and assess performance.
A segment’s performance is primarily evaluated based on segment operating income, which excludes amortization of intangible assets, impairment of goodwill and other intangible assets, restructuring charges, and certain corporate costs or credits not associated with the operations of the segment. Corporate and other costs excluded from a segment’s performance are separately stated below and include costs that are related to functional areas such as finance, information technology, legal, and human resources. The CODM uses operating income primarily in the annual budget and forecasting process. The CODM considers budget-to-actual variances on a quarterly basis for operating income when making decisions about the allocation of operating and capital resources to each segment. Significant expenses are reviewed by the CODM on a consolidated basis and not at the operating segment level. We believe that segment operating income, as defined above, is an appropriate measure for evaluating the operating performance of our segments. However, this measure should be considered in addition to, and not as a substitute for, or superior to, operating income or other measures of financial performance prepared in accordance with U.S. GAAP. The accounting policies of each of our operating and reportable segments are materially consistent with those described in
Note 2: Significant Accounting Policies
of the audited consolidated financial statements and notes thereto included in our 2024 Annual Report.
The Performance Sensing segment serves the automotive and HVOR industries through the development and manufacture of sensors, high-voltage solutions (i.e., electrical protection components), and other solutions that are used in mission-critical systems and applications. Examples include those used in subsystems of automobiles, on-road trucks, and off-road equipment, such as tire pressure monitoring, thermal management, electrical protection, regenerative braking, powertrain (engine/transmission), and exhaust management. These products are used in subsystems that, among other things, improve operating performance and efficiency and contribute to environmentally sustainable and safe solutions.
The Sensing Solutions segment primarily serves the industrial and aerospace industries through the development and manufacture of a broad portfolio of application-specific sensor and electrical protection products used in a diverse range of industrial markets, including the appliance, HVAC, water management, operator controls, charging infrastructure, renewable
energy generation, green hydrogen production, and microgrid applications and markets, as well as the aerospace market, including commercial aircraft, defense, and aftermarket markets.
Some of the products and solutions sold by the Sensing Solutions segment include pressure, temperature, and position sensors, motor and compressor protectors, high-voltage contactors, solid state relays, bimetal electromechanical controls, power inverters, charge controllers, battery management systems, operator controls, and power conversion systems. Sensing Solutions products perform many functions, including prevention of damage from excess heat or electrical current, optimization of system performance, low-power circuit control, renewable energy generation, and power conversion from direct current power to alternating current power.
The following table presents net revenue, segment and non-segment operating expenses, and segment and non-segment operating income for the reportable segments and other operating results not allocated to our reportable segments for the three and six months ended June 30, 2025 and 2024:
For the three months ended
For the six months ended
June 30, 2025
June 30, 2024
June 30, 2025
June 30, 2024
Net revenue:
Performance Sensing
$
652,225
$
723,921
$
1,302,641
$
1,437,239
Sensing Solutions
291,159
268,071
551,998
525,910
Other
—
43,543
—
79,095
Total net revenue
$
943,384
$
1,035,535
$
1,854,639
$
2,042,244
Segment and non-segment operating expenses
(1)
:
Performance Sensing
$
505,349
$
562,513
$
1,012,889
$
1,106,863
Sensing Solutions
203,123
188,396
387,896
373,941
Other
—
34,339
—
63,110
Total segment and non-segment operating expenses
$
708,472
$
785,248
$
1,400,785
$
1,543,914
Segment and non-segment operating income (as defined above):
Performance Sensing
(1)
$
146,876
$
161,408
$
289,752
$
330,376
Sensing Solutions
(1)
88,036
79,675
164,102
151,969
Other
(1)
—
9,204
—
15,985
Total segment and non-segment operating income
234,912
250,287
453,854
498,330
Corporate and other
(
69,054
)
(
77,764
)
(
138,243
)
(
141,718
)
Amortization of intangible assets
(
21,184
)
(
39,085
)
(
41,761
)
(
77,600
)
Restructuring and other charges, net
(
6,612
)
(
3,491
)
(
13,592
)
(
4,273
)
Operating income
138,062
129,947
260,258
274,739
Interest expense
(
37,679
)
(
40,863
)
(
75,652
)
(
79,258
)
Interest income
4,467
5,802
8,757
9,540
Other, net
930
4,097
3,058
(
7,447
)
Income before taxes
$
105,780
$
98,983
$
196,421
$
197,574
___________________________________
(1)
Other segment and non-segment expenses include associated cost of revenue, research and development, and selling, general and administrative expenses.
The following table presents depreciation and amortization expense for our reportable segments and corporate and other for the three and six months ended June 30, 2025 and 2024:
For the three months ended
For the six months ended
June 30, 2025
June 30, 2024
June 30, 2025
June 30, 2024
Depreciation and amortization:
Performance Sensing
$
24,097
$
24,242
$
49,079
$
48,202
Sensing Solutions
3,986
3,779
7,876
7,903
Corporate and other
(1)
26,439
44,557
59,106
88,511
Total depreciation and amortization
$
54,522
$
72,578
$
116,061
$
144,616
__________________________
(1)
Included within corporate and other is amortization of intangible assets, accelerated depreciation recognized in connection with restructuring actions, and depreciation of certain assets. We do not allocate these amounts to our segments. This treatment is consistent with the financial information reviewed by our chief operating decision maker.
The following table presents additions to PP&E and capitalized software for our reportable segments and corporate and other for the three and six months ended June 30, 2025 and 2024:
For the three months ended
For the six months ended
June 30, 2025
June 30, 2024
June 30, 2025
June 30, 2024
Additions to property, plant and equipment and capitalized software:
Performance Sensing
$
18,555
$
27,243
$
41,605
$
58,256
Sensing Solutions
2,719
5,557
5,782
8,820
Corporate and other
4,111
4,961
10,573
12,815
Total additions to property, plant and equipment and capitalized software
$
25,385
$
37,761
$
57,960
$
79,891
Geographic Area Information
The following tables present net revenue by geographic area and by significant country for the three and six months ended June 30, 2025 and 2024. In these tables, net revenue is aggregated according to the location of our subsidiaries.
The following tables present PP&E, net, by geographic area and by significant country as of June 30, 2025 and 2024. In these tables, PP&E, net is aggregated based on the location of our subsidiaries.
June 30,
2025
December 31,
2024
Property, plant and equipment, net:
Americas
$
291,147
$
301,900
Europe
137,469
141,396
Asia and rest of world
377,387
378,357
Property, plant and equipment, net
$
806,003
$
821,653
June 30,
2025
December 31,
2024
Property, plant and equipment, net:
United States
$
113,552
$
121,783
China
255,658
266,104
Mexico
177,463
179,980
Bulgaria
100,891
108,093
United Kingdom
24,830
21,147
Malaysia
117,503
108,118
All other
16,106
16,428
Property, plant and equipment, net
$
806,003
$
821,653
16.
Disposals
Insights Business
In August 2024, we executed a purchase agreement whereby we agreed to sell the Insights Business to an affiliate of Balmoral Funds ("the Buyer"). The closing of the transaction ("Closing") occurred in the third quarter of 2024, at which time net assets transferred to the Buyer.
Concurrent with the Closing, the parties entered into a Transition Services Agreement ("TSA") and a Supply Agreement. The terms of the TSA require that we provide various forms of commercial, operational, and back-office support to the Buyer. The Supply Agreement commenced at Closing and has a term of
five years
or less. The terms of this agreement require that we sell certain tire pressure monitoring system products to the Buyer over the term of the agreement.
For the three and six months ended June 30, 2024, the Insights Business was included in our Other segment.
Magnetic Speed and Position Business ("MSP Business")
In November 2024, we executed a purchase agreement whereby we agreed to sell the MSP Business to a third party. The closing of the transaction occurred in the first quarter of 2025, at which time net assets transferred to the Buyer.
This Quarterly Report on Form 10-Q includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by terminology such as "may," "will," "could," "should," "expect," "anticipate," "believe," "estimate," "predict," "project," "forecast," "continue," "intend," "plan," "potential," "opportunity," "guidance," and similar terms or phrases. Forward-looking statements involve, among other things, expectations, projections, and assumptions about future financial and operating results, objectives, business and market outlook, megatrends, priorities, growth, shareholder value, capital expenditures, cash flows, demand for products and services, share repurchases, and Sensata’s strategic initiatives, including those relating to acquisitions and dispositions and the impact of such transactions on our strategic and operational plans and financial results. These statements are subject to risks, uncertainties, and other important factors relating to our operations and business environment, and we can give no assurances that these forward-looking statements will prove to be correct.
A wide variety of potential risks, uncertainties, and other factors could materially affect our ability to achieve the results either expressed or implied by these forward-looking statements, including, but not limited to, risks related to instability and changes in the global markets, supplier interruption or non-performance, changes in trade-related tariffs and risks with uncertain trade environments, the acquisition or disposition of businesses, adverse conditions or competition in the industries upon which we are dependent, intellectual property, product liability, warranty, and recall claims, public health crises, market acceptance of new product introductions and product innovations, labor disruptions or increased labor costs, changes in existing environmental or safety laws, regulations, and programs, and the impact of our recently reported cybersecurity incident or other incidents that may occur in the future.
Investors and others should carefully consider the foregoing factors and other uncertainties, risks, and potential events including, but not limited to, those described in
Item 1A: Risk Factors
included in our 2024 Annual Report and as may be updated from time to time in
Item 1A: Risk Factors
included in our quarterly reports on Form 10-Q or other subsequent filings with the United States Securities and Exchange Commission. All such forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update these statements other than as required by law.
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of our financial condition and results of operations supplements should be read in conjunction with the discussion in
Item 7: Management's Discussion and Analysis of Financial Condition and Results of Operations
included in our 2024 Annual Report. The following discussion should also be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto (the "Financial Statements") included elsewhere in this Report. Amounts and percentages in the following discussions and tables have been calculated based on unrounded numbers. Accordingly, certain amounts may not appear to recalculate due to the effect of rounding.
Overview
Net revenue for the three months ended June 30, 2025 was $943.4 million, a decrease of 8.9% on a reported basis compared to $1,035.5 million in the prior period. Excluding an increase of 0.9% attributed to changes in foreign currency exchange rates and a decrease of 8.3% related to the effect of disposals, net revenue decreased 1.5% on an organic basis. Organic revenue growth (or decline), discussed throughout this
Item 2: Management's Discussion and Analysis of Financial Condition and Results of Operations
(this "MD&A"), is a financial measure not presented in accordance with U.S. GAAP. Refer to
Non-GAAP Financial Measures
included elsewhere in this MD&A for additional information regarding our use of organic revenue growth (or decline). Net revenue for the six months ended June 30, 2025 was $1,854.6 million, a decrease of 9.2% compared to $2,042.2 million in the prior period. Excluding an increase of 0.2% attributed to changes in foreign currency exchange rates and a decrease of 6.4% related to the effect of disposals, net revenue decreased 3.0% on an organic basis.
Operating income for the three months ended June 30, 2025 was $138.1 million (14.6% of net revenue), an increase of $8.1 million, or 6.2% compared to operating income of $129.9 million (12.5% of net revenue) in the three months ended June 30, 2024. Operating income for the six months ended June 30, 2025 decreased $14.5 million, or 5.3%, to $260.3 million (14.0% of net revenue) from $274.7 million (13.5% of net revenue) in the six months ended June 30, 2024. Refer to
Results of Operations
included elsewhere in this MD&A for additional discussion of our earnings results for the three and six months ended June 30, 2025 compared to the prior periods.
We generated $260.1 million of operating cash flows in the six months ended June 30, 2025, ending the quarter with $661.8 million in cash and cash equivalents. In the six months ended June 30, 2025, we used cash of approximately $58.0 million for capital expenditures, $35.5 million for payment of cash dividends, and $120.6 million for share repurchases as part of our share repurchase plan.
The table below presents our historical results of operations, in millions of dollars and as a percentage of net revenue, for the three and six months ended June 30, 2025 compared to the three and six months ended June 30, 2024. We have derived the results of operations from the Financial Statements included elsewhere in this Report. Amounts and percentages in the table below have been calculated based on unrounded numbers. Accordingly, certain amounts may not appear to recalculate due to the effect of rounding.
For the three months ended
For the six months ended
June 30, 2025
June 30, 2024
June 30, 2025
June 30, 2024
Amount
Percent
Amount
Percent
Amount
Percent
Amount
Percent
Net revenue:
Performance Sensing
$
652.2
69.1
%
$
723.9
69.9
%
$
1,302.6
70.2
%
$
1,437.2
70.4
%
Sensing Solutions
291.2
30.9
268.1
25.9
552.0
29.8
525.9
25.8
Other
—
—
43.5
4.2
—
—
79.1
3.9
Net revenue
943.4
100.0
1,035.5
100.0
1,854.6
100.0
2,042.2
100.0
Operating costs and expenses
805.3
85.4
905.6
87.5
1,594.4
86.0
1,767.5
86.5
Operating income
138.1
14.6
129.9
12.5
260.3
14.0
274.7
13.5
Interest expense
(37.7)
(4.0)
(40.9)
(3.9)
(75.7)
(4.1)
(79.3)
(3.9)
Interest income
4.5
0.5
5.8
0.6
8.8
0.5
9.5
0.5
Other, net
0.9
0.1
4.1
0.4
3.1
0.2
(7.4)
(0.4)
Income before taxes
105.8
11.2
99.0
9.6
196.4
10.6
197.6
9.7
Provision for income taxes
45.1
4.8
27.3
2.6
65.8
3.5
49.9
2.4
Net income
$
60.7
6.4
%
$
71.7
6.9
%
$
130.6
7.0
%
$
147.7
7.2
%
Net Revenue
Net revenue for the three months ended June 30, 2025 decreased 8.9% compared to the prior period. Net revenue decreased 1.5% on an organic basis, which excludes an increase of 0.9% attributed to changes in foreign currency exchange rates and a decrease of 8.3% due primarily to the effects of the divestitures of the Insights Business in the third quarter of 2024 and the MSP Business in the first quarter of 2025.
Net revenue for the six months ended June 30, 2025 decreased 9.2% compared to the prior period. Net revenue decreased 3.0% on an organic basis, which excludes an increase of 0.2% attributed to changes in foreign currency exchange rates and a decrease of 6.4% due primarily to the effects of the divestitures of the Insights Business in the third quarter of 2024 and the MSP Business in the first quarter of 2025.
Performance Sensing
Performance Sensing net revenue for the three months ended June 30, 2025 decreased 9.9% on a reported basis, which includes the effects of the divestiture of the MSP Business in the first quarter of 2025, and 6.1% on an organic basis compared to the prior period, which was primarily due to decreases in automotive and HVOR production in North America and Europe.
Performance Sensing net revenue for the six months ended June 30, 2025 decreased 9.4% on a reported basis and 6.8% on an organic basis compared to the prior period, which was primarily due to lower automotive and HVOR production levels in North America and Europe.
Sensing Solutions
Sensing Solutions net revenue for the three months ended June 30, 2025 increased 8.6% on a reported basis and 10.7% on an organic basis compared to the prior period, which is primarily due to content growth in our industrial market.
Sensing Solutions net revenue for the six months ended June 30, 2025 increased 5.0% on a reported basis and 7.4% on an organic basis compared to the prior period, which is primarily due to content growth in our industrial market.
Operating costs and expenses for the three and six months ended June 30, 2025 and 2024 are presented, in millions of dollars and as a percentage of net revenue, in the following table. Amounts and percentages in the table below have been calculated based on unrounded numbers. Accordingly, certain amounts may not appear to recalculate due to the effect of rounding.
For the three months ended
For the six months ended
June 30, 2025
June 30, 2024
June 30, 2025
June 30, 2024
Amount
Percent
Amount
Percent
Amount
Percent
Amount
Percent
Operating costs and expenses:
Cost of revenue
$
657.1
69.7
%
$
724.4
70.0
%
$
1,295.8
69.9
%
$
1,413.7
69.2
%
Research and development
32.6
3.5
45.3
4.4
69.4
3.7
90.6
4.4
Selling, general and administrative
87.8
9.3
93.3
9.0
173.9
9.4
181.3
8.9
Amortization of intangible assets
21.2
2.2
39.1
3.8
41.8
2.3
77.6
3.8
Restructuring and other charges, net
6.6
0.7
3.5
0.3
13.6
0.7
4.3
0.2
Total operating costs and expenses
$
805.3
85.4
%
$
905.6
87.5
%
$
1,594.4
86.0
%
$
1,767.5
86.5
%
Cost of revenue
For the three months ended June 30, 2025, cost of revenue as a percentage of net revenue decreased from the prior period, primarily due to a decrease in product line and product lifecycle management charges, partially offset by the unfavorable effect of changes in foreign currency exchange rates.
For the six months ended June 30, 2025, cost of revenue as a percentage of net revenue increased from the prior period, primarily due to (1) the net impacts of inflation on material and logistics costs and pricing recoveries from customers and (2) unfavorable product mix, partially offset by the favorable effect of changes in foreign currency exchange rates.
Research and development expense
For the three and six months ended June 30, 2025, research and development expense decreased primarily as a result of the divestiture of the Insights Business in the third quarter of 2024 and restructuring actions impacting certain product lines.
Selling, general and administrative expense
For the three and six months ended June 30, 2025, SG&A expense did not fluctuate materially from the prior periods.
Amortization of intangible assets
For the three and six months ended June 30, 2025, amortization of intangible assets decreased from the prior period, primarily due to the divestiture of the Insights Business, resulting in approximately $9.8 million and $19.7 million, respectively, of lower amortization expense during fiscal year 2025, and the effect of amortization of intangible assets in accordance with their expected economic benefit, which generally results in acceleration of amortization expense in the early years of the life of an intangible asset.
Restructuring and other charges, net
In the three and six months ended June 30, 2025, restructuring and other charges, net increased from the prior periods, primarily due to the loss on the sale of the Magnetic Speed and Positioning business and charges associated with the 2H 2024 Plan.
Refer to
Note 5: Restructuring and Other Charges, Net
and
Note 16: Disposals
of the Financial Statements, included elsewhere in this Report, for additional information regarding the components of restructuring and other charges, net.
Operating Income
For the three months ended June 30, 2025, operating income was $138.1 million, compared to $129.9 million in the prior period. This favorable impact was driven primarily by (1) a decrease in product line and product lifecycle management charges, (2) a $17.9 million decrease in amortization of intangibles, and (3) cost savings as a result of actions taken as part of the 2H 2024 and Q3 2023 Plans, partially offset by (1) the impact of organic revenue declines and (2) the dispositions of the Insights Business in the third quarter of 2024 and the MSP Business in the first quarter of 2025.
For the six months ended June 30, 2025, operating income was $260.3 million, compared to $274.7 million in the prior period. This unfavorable impact was driven primarily by (1) the impact of organic revenue declines and (2) the disposition of the Insights Business in the third quarter of 2024, partially offset by (1) the favorable impact of foreign exchange rates, (2) a $35.8 million decrease in amortization of intangibles and (3) cost savings as a result of actions taken as part of the 2H 2024 and Q3 2023 Plans.
Interest Expense
For the three and six months ended June 30, 2025, interest expense did not fluctuate materially from the prior periods.
Interest Income
For the three and six months ended June 30, 2025, interest income did not fluctuate materially from the prior periods.
Other, Net
Other, net primarily includes currency remeasurement gains and losses on net monetary assets, gains and losses on foreign currency and commodity forward contracts not designated as hedging instruments, mark-to-market gains and losses on investments, losses related to debt refinancing, and the portion of our net periodic benefit cost excluding service cost.
For the three months ended June 30, 2025, other, net represented a net gain of $0.9 million, an unfavorable impact on earnings of $3.2 million compared to a net gain of $4.1 million in the prior period. This unfavorable impact was primarily due to a lesser gain recognized on commodity forward contracts and the currency remeasurement of net monetary assets in 2025 compared to the prior period.
For the six months ended June 30, 2025, other, net represented a net gain of $3.1 million, a favorable impact on earnings of $10.5 million compared to a net loss of $7.4 million in the prior period. This favorable impact was primarily due to the absence of a $14.8 million loss recognized in the first quarter of 2024 as a result of observable price changes related to an equity investment held using the measurement alternative.
Refer to
Note 13: Fair Value Measures
and
Note 6: Other, Net
of the Financial Statements, included elsewhere in this Report, for additional details of our hedge accounting contracts and the components of other, net, respectively.
Provision for Income Taxes
The provision for income taxes consists of (1) current tax expense, which relates primarily to our profitable operations in tax jurisdictions with limited or no net operating loss carryforwards and withholding taxes related to management fees, royalties, and the repatriation of foreign earnings; and (2) deferred tax expense (or benefit), which represents adjustments in book-to-tax basis differences primarily related to (a) book versus tax basis in intangible assets, (b) changes in net operating loss carryforwards and tax credits, and (c) changes in withholding taxes on unremitted earnings.
Non-GAAP Financial Measures
This section provides additional information regarding certain non-GAAP financial measures, including organic revenue growth (or decline), adjusted operating income, adjusted operating margin, adjusted net income, adjusted earnings per share ("EPS"), free cash flow, adjusted corporate and other expenses, net debt, gross and net leverage ratio, and adjusted earnings before interest, taxes, depreciation, and amortization ("EBITDA"), which are used by our management, Board of Directors, and investors. We use these non-GAAP financial measures internally to make operating and strategic decisions, including the preparation of our annual operating plan, evaluation of our overall business performance, and as a factor in determining compensation for certain employees.
The use of our non-GAAP financial measures has limitations. They should be considered as supplemental in nature and are not intended to be considered in isolation from, or as an alternative to, reported net revenue growth (or decline), operating income, operating margin, net income, diluted EPS, net cash provided by operating activities, corporate and other expenses, or total debt and finance lease obligations, respectively, calculated in accordance with U.S. GAAP. In addition, our measures of organic revenue growth (or decline), adjusted operating income, adjusted operating margin, adjusted net income, adjusted EPS, free cash flow, adjusted corporate and other expenses, gross and net leverage ratio, and adjusted EBITDA may not be the same as, or comparable to, similar non-GAAP financial measures presented by other companies.
Organic revenue growth (or decline) and market outgrowth
Organic revenue growth (or decline) is defined as the reported percentage change in net revenue calculated in accordance with U.S. GAAP, excluding the period-over-period impact of foreign exchange rate differences as well as the net impact of material acquisitions and divestitures and product life-cycle management for the 12-month period following the respective transaction date(s).
We believe that organic revenue growth (or decline) provides investors with helpful information with respect to our operating performance, and we use organic revenue growth (or decline) to evaluate our ongoing operations as well as for internal planning and forecasting purposes. We believe that organic revenue growth (or decline) provides useful information in evaluating the results of our business because it excludes items that we believe are not indicative of ongoing performance or that we believe impact comparability with the prior period.
Market outgrowth is calculated as organic revenue growth less our weighted market growth. Our weighted market growth is calculated using our regional and platform sales mix, as applicable, in the corresponding prior period. Market outgrowth is used to describe the impact of an increasing quantity and value of our products used in customer systems and applications above market growth. We believe this provides a more meaningful comparison of our revenue growth relative to the markets we serve.
Adjusted operating income, adjusted operating margin, adjusted net income, and adjusted EPS
We define adjusted operating income as operating income (or loss), determined in accordance with U.S. GAAP, adjusted to exclude certain non-GAAP adjustments which are described under the heading
Non-GAAP Adjustments
below. Adjusted operating margin is calculated by dividing adjusted operating income (or loss) by net revenue determined in accordance with U.S. GAAP. We define adjusted net income as follows: net income (or loss) determined in accordance with U.S. GAAP, excluding certain non-GAAP adjustments which are described under the heading
Non-GAAP Adjustments
below. Adjusted EPS is calculated by dividing adjusted net income by the number of diluted weighted-average ordinary shares outstanding in the period as determined in accordance with U.S. GAAP.
Management uses adjusted operating income, adjusted operating margin, adjusted net income, and adjusted EPS (and the constant currency equivalent of each) as measures of operating performance, for planning purposes (including the preparation of our annual operating budget), to allocate resources to enhance the financial performance of our business, to evaluate the effectiveness of our business strategies, in communications with our Board of Directors and investors concerning our financial performance, and as factors in determining compensation for certain employees. We believe investors and securities analysts also use these non-GAAP financial measures in their evaluation of our performance and the performance of other similar companies. These non-GAAP financial measures are not measures of liquidity.
Free cash flow
Free cash flow is defined as net cash provided by operating activities less additions to property, plant and equipment and capitalized software. We believe free cash flow is useful to management and investors as a measure of cash generated by business operations that will be used to repay scheduled debt maturities and can be used to, among other things, fund acquisitions, repurchase ordinary shares, or accelerate the repayment of debt obligations.
Adjusted corporate and other expenses
Adjusted corporate and other expenses is defined as corporate and other expenses calculated in accordance with U.S. GAAP, excluding the portion of non-GAAP adjustments described below that relate to corporate and other expenses. We believe adjusted corporate and other expenses is useful to management and investors in understanding the impact of non-GAAP adjustments on operating expenses not allocated to our segments.
Adjusted EBITDA
Adjusted EBITDA is defined as net income (or loss), determined in accordance with U.S. GAAP, excluding interest expense, interest income, and provision for (or benefit from) income taxes, depreciation expense, amortization of intangible assets, and the following non-GAAP adjustments, if applicable: (1) restructuring related and other, (2) financing and other transaction costs, and (3) other, net. Refer to
Non-GAAP Adjustments
below for additional discussion of these adjustments.
Gross leverage ratio represents gross debt (total debt and finance lease obligations) divided by last twelve months ("LTM") adjusted EBITDA. We believe that gross leverage ratio is a useful measure to management and investors in understanding trends in our overall financial condition.
Net leverage ratio
Net leverage ratio represents net debt (total debt, finance lease and other financing obligations less cash and cash equivalents) divided by LTM adjusted EBITDA. We believe that the net leverage ratio is a useful measure to management and investors in understanding trends in our overall financial condition.
Non-GAAP adjustments
Many of our non-GAAP adjustments relate to a series of strategic initiatives developed by our management aimed at better positioning us for future revenue growth and an improved cost structure. These initiatives have been modified from time to time to reflect changes in overall market conditions and the competitive environment facing our business. These initiatives include, among other items, acquisitions, divestitures, restructurings of certain business, supply chain or corporate activities, and various financing transactions. We describe these adjustments in more detail below, each of which is net of current tax impacts, as applicable.
•
Restructuring related and other
: includes net charges related to certain restructuring and other exit activities, other costs (or income) that we believe are either unique or unusual to the identified reporting period, and the impact of commodity forward contacts that we believe impact comparisons to prior period operating results. Such costs include charges related to optimization of our manufacturing processes to increase productivity. This type of activity occurs periodically; however, each action is unique, discrete, and driven by various facts and circumstances. Such amounts are excluded from internal financial statements and analyses that management uses in connection with financial planning and in its review and assessment of our operating and financial performance, including the performance of our segments.
•
Financing and other transaction costs
: includes costs incurred, such as legal, accounting, and other professional services, that are directly related to an acquisition, divestiture, or equity financing transaction, expenses related to compensation arrangements entered into concurrent with the closing of an acquisition, adjustments related to changes in the fair value of acquisition-related contingent consideration amounts, and historical adjustments to exclude step-up depreciation in our non-GAAP measures. Beginning with the three months ended December 31, 2024, we discontinued the use of adjustments to exclude step-up depreciation in our non-GAAP measures. Prior periods have not been recast.
•
Amortization of intangible assets
: includes amortization of intangible assets. Beginning with the three months ended December 31, 2024, we started adjusting operating income and net income to exclude the amortization of all our intangible assets. Prior periods have not been recast.
•
Other, net:
includes expenses (or income) recorded within Other, net on our condensed consolidated statements of operations. Beginning with the three months ended March 31, 2025, we started adjusting net income to exclude the impacts of these losses (or gains). Prior periods have been recast. Refer to
Note 6: Other, Net
of the Financial Statements, included elsewhere in this Quarterly Report, for additional details of the components of Other, net.
•
Deferred taxes and other tax related
: includes adjustments for deferred taxes and other timing differences including, but not limited to, book-to-tax basis differences on the fair value of intangible assets and goodwill, the utilization of net operating losses, and adjustments to our valuation allowance in connection with certain transactions and tax law changes. Other tax related items include certain adjustments to unrecognized tax benefits and withholding tax on repatriation of foreign earnings.
•
Amortization of debt issuance costs:
represents interest expense related to the amortization of deferred financing costs as well as debt discounts, net of premiums.
•
Where applicable, the current income tax effect of non-GAAP adjustments.
Our definition of adjusted net income excludes the deferred provision for (or benefit from) income taxes and other tax related items described above. As we treat deferred income taxes as an adjustment to compute adjusted net income, the deferred income tax effect associated with the reconciling items presented below would not change adjusted net income for any period presented.
The following tables present reconciliations of certain financial measures calculated in accordance with U.S. GAAP to the related non-GAAP financial measures for the three months ended June 30, 2025 and 2024. Refer to the
Non-GAAP Adjustments
section above for additional information regarding these adjustments. Amounts and percentages in the tables below have been calculated based on unrounded numbers, accordingly, certain amounts may not appear to recalculate due to the effect of rounding.
For the three months ended June 30, 2025
(Dollars in millions, except per share amounts)
Operating Income
Operating Margin
Income Taxes
Net Income
Diluted EPS
Reported (GAAP)
$
138.1
14.6
%
$
45.1
$
60.7
$
0.41
Non-GAAP adjustments:
Restructuring related and other
(a)
16.3
1.7
(0.6)
15.6
0.11
Financing and other transaction costs
(b)
3.6
0.4
0.1
3.6
0.02
Amortization of intangible assets
(c)
21.2
2.2
—
21.2
0.14
Amortization of debt issuance costs
—
—
—
1.2
0.01
Other, net
—
—
(0.1)
(1.0)
(0.01)
Deferred taxes and other tax related
—
—
26.0
26.0
0.18
Total adjustments
41.0
4.3
25.4
66.7
0.45
Adjusted (non-GAAP)
$
179.1
19.0
%
$
19.7
$
127.3
$
0.87
For the three months ended June 30, 2024
(Dollars in millions, except per share amounts)
Operating Income
Operating Margin
Income Taxes
Net Income
Diluted EPS
Reported (GAAP)
$
129.9
12.5
%
$
27.3
$
71.7
$
0.47
Non-GAAP adjustments:
Restructuring related and other
(a)
26.7
2.6
(0.8)
25.9
0.17
Financing and other transaction costs
(b)
2.7
0.3
(1.0)
1.7
0.01
Amortization of intangible assets
(c)
37.3
3.6
—
37.3
0.25
Amortization of debt issuance costs
—
—
—
1.6
0.01
Other, net
—
—
0.9
(3.2)
(0.02)
Deferred taxes and other tax related
—
—
4.2
4.2
0.03
Total adjustments
66.7
6.4
3.3
67.6
0.45
Adjusted (non-GAAP)
$
196.7
19.0
%
$
24.0
$
139.3
$
0.92
The following tables present reconciliations of certain financial measures calculated in accordance with U.S. GAAP to the related non-GAAP financial measures for the six months ended June 30, 2025 and 2024.
(a)
The following table presents the components of our restructuring related and other non-GAAP adjustment to net income for the three and six months ended June 30, 2025 and 2024 (amounts have been calculated based on unrounded numbers, accordingly, certain amounts may not appear to recalculate due to the effect of rounding):
For the three months ended June 30,
For the six months ended June 30,
(In millions)
2025
2024
2025
2024
Business and corporate repositioning
(i)
$
16.2
$
26.8
$
34.3
$
29.2
Other
0.1
(0.1)
0.3
(0.5)
Income tax effect
(ii)
(0.6)
(0.8)
0.9
(1.2)
Total non-GAAP restructuring related and other
(iii)
$
15.6
$
25.9
$
35.5
$
27.5
__________________________
i.
Primarily includes charges related to repositioning our business and corporate functions to more effectively respond to the challenges that face the business, including severance, contract termination costs, charges related to asset write-downs, and other various restructuring-related charges.
ii.
We treat deferred taxes as a non-GAAP adjustment. Accordingly, the income tax effect of the restructuring related and other non-GAAP adjustment refers only to the current income tax effect.
iii.
Total presented is the non-GAAP adjustment to net income. Certain portions of these adjustments are non-operating and are excluded from the non-GAAP adjustments to operating income.
(b)
The following table presents the components of our financing and other transaction costs non-GAAP adjustment to net income for the three and six months ended June 30, 2025 and 2024 (amounts have been calculated based on unrounded numbers, accordingly, certain amounts may not appear to recalculate due to the effect of rounding):
For the three months ended June 30,
For the six months ended June 30,
(In millions)
2025
2024
2025
2024
Transaction loss
(i)
$
3.9
$
(0.4)
$
8.6
2.7
Merger and acquisition compensation arrangements
(ii)
(0.3)
2.8
0.4
4.1
Acquisition-related depreciation
—
0.3
—
0.5
Income tax effect
(iii)
0.1
(1.0)
0.1
(1.2)
Total financing and other transaction costs
(iv)
$
3.6
$
1.7
$
9.1
$
6.1
__________________________
i.
Primarily includes losses or gains related to the divestiture of a business, costs incurred, including for legal, accounting, and other professional services, that are directly related to an acquisition, divestiture, or other transaction. In the six months ended June 30, 2025, this line includes costs and losses associated with the disposition of the Magnetic Speed and Positioning ("MSP") Business. Refer to
Note 16: Disposals
for further information on this transaction.
ii.
Primarily relates to earnout compensation arrangements entered into concurrent with the closing of an acquisition and compensation in connection with the closing of a transaction.
iii.
We treat deferred taxes as a non-GAAP adjustment. Accordingly, the income tax effect of financing and transaction related and other non-GAAP adjustment refers only to the current income tax effect.
iv.
Total presented is the non-GAAP adjustment to net income. Certain portions of these adjustments are non-operating and are excluded from the non-GAAP adjustments to operating income.
(c)
In the three months ended December 31, 2024, we discontinued the use of adjustments to exclude step-up depreciation in our non-GAAP measures and we adjusted operating income and net income to exclude the amortization of all our intangible assets. The three and six months ended June 30, 2024 have not been recast. If we had recast this non-GAAP measure for the three and six months ended June 30, 2024, adjusted operating income and adjusted net income would have increased by an additional $1.8 million and $3.2 million, respectively.
The following table provides a reconciliation of net cash provided by operating activities in accordance with U.S. GAAP to free cash flow.
For the six months ended June 30,
(In millions)
2025
2024
Net cash provided by operating activities (GAAP)
$
260.1
$
249.9
Additions to property, plant and equipment and capitalized software
(58.0)
(87.2)
Free cash flow (non-GAAP)
$
202.1
$
162.7
The following table provides a reconciliation of corporate and other expenses in accordance with U.S. GAAP to adjusted corporate and other expenses.
For the three months ended June 30,
For the six months ended June 30,
(In millions)
2025
2024
2025
2024
Corporate and other expenses (GAAP)
$
(69.1)
$
(77.8)
$
(138.2)
$
(141.7)
Restructuring related and other
12.9
24.2
28.6
26.4
Financing and other transaction costs
0.3
1.8
1.4
5.4
Total adjustments
13.2
25.9
30.0
31.8
Adjusted corporate and other expenses (non-GAAP)
$
(55.8)
$
(51.8)
$
(108.3)
$
(110.0)
The following table provides a reconciliation of net income in accordance with U.S. GAAP to adjusted EBITDA.
The following table provides a reconciliation of total debt and finance lease obligations in accordance with U.S. GAAP to gross and net leverage ratios.
(Dollars in millions)
June 30,
2025
December 31,
2024
Current portion of long-term debt and finance lease obligations
$
2.2
$
2.4
Finance lease obligations, less current portion
20.0
21.0
Long-term debt, net
3,178.5
3,176.1
Total debt and finance lease obligations
3,200.6
3,199.5
Plus: debt premium, net
0.9
1.0
Less: deferred financing costs
(22.4)
(24.9)
Total gross indebtedness
$
3,222.1
$
3,223.4
Adjusted EBITDA (LTM)
$
840.3
$
882.8
Gross leverage ratio
3.8
3.7
Total gross indebtedness
$
3,222.1
$
3,223.4
Less: cash and cash equivalents
661.8
593.7
Net debt
$
2,560.3
$
2,629.7
Adjusted EBITDA (LTM)
$
840.3
$
882.8
Net leverage ratio
3.0
3.0
Liquidity and Capital Resources
As of June 30, 2025 and December 31, 2024, we held cash and cash equivalents in the following regions (amounts have been calculated based on unrounded numbers, accordingly, certain amounts may not appear to recalculate due to the effect of rounding):
(In millions)
June 30,
2025
December 31,
2024
United Kingdom
$
5.1
$
4.4
United States
9.0
6.9
The Netherlands
386.7
256.3
China
181.1
272.2
Other
79.9
53.9
Total
$
661.8
$
593.7
The amount of cash and cash equivalents held in these geographic regions fluctuates throughout the year due to a variety of factors, such as our use of intercompany loans and dividends and the timing of cash receipts and disbursements in the normal course of business. Our earnings are not considered to be permanently reinvested in certain jurisdictions in which they were earned. We recognize a deferred tax liability on these unremitted earnings to the extent the remittance of such earnings cannot be recovered in a tax-free manner.
In certain jurisdictions, our cash balances are subject to withholding taxes immediately upon withdrawal of funds to a different jurisdiction. In addition, in order to take advantage of incentive programs offered by various jurisdictions, including tax incentives, we are required to maintain minimum cash balances in these jurisdictions. The transfer of cash from these jurisdictions could result in loss of incentives or higher cash tax expense, but those impacts are not expected to be material.
Our cash and cash equivalents balances are held in the following significant currencies (amounts in the tables below have been calculated based on unrounded numbers, accordingly, certain amounts may not appear to recalculate due to the effect of rounding):
As of June 30, 2025
(In millions)
United States Dollar ("USD")
Euro ("EUR")
British Pound Sterling ("GBP")
Chinese Renminbi ("CNY")
Other
United Kingdom
$
1.0
€
0.0
£
2.9
¥
—
United States
8.9
0.1
0.0
—
The Netherlands
377.0
8.0
0.3
—
China
67.3
—
—
816.3
Other
62.1
2.8
—
—
Total
$
516.3
€
10.9
£
3.2
¥
816.3
USD Equivalent
$
12.8
$
4.4
$
113.8
$
14.5
As of December 31, 2024
(In millions)
USD
EUR
GBP
CNY
Other
United Kingdom
$
0.1
€
0.0
£
3.1
¥
—
United States
6.9
0.0
0.0
—
The Netherlands
247.8
7.4
0.5
—
China
73.1
—
—
1,453.6
Other
41.3
2.3
—
—
Total
$
369.2
€
9.7
£
3.6
¥
1,453.6
USD Equivalent
$
10.1
$
4.5
$
199.2
$
10.7
Cash Flows:
The table below summarizes our primary sources and uses of cash for the six months ended June 30, 2025 and 2024. We have derived these summarized statements of cash flows from the Financial Statements included elsewhere in this Report. Amounts in the table below have been calculated based on unrounded numbers. Accordingly, certain amounts may not appear to recalculate due to the effect of rounding.
For the six months ended
(In millions)
June 30, 2025
June 30, 2024
Net cash provided by/(used in):
Operating activities:
Net income adjusted for non-cash items
$
297.4
$
318.0
Changes in operating assets and liabilities, net
(37.3)
(68.0)
Operating activities
260.1
249.9
Investing activities
(33.6)
(85.2)
Financing activities
(160.8)
365.1
Effects of exchange rate differences
2.4
(4.9)
Net change
$
68.1
$
524.9
Operating activities.
Net cash provided by operating activities for the six months ended June 30, 2025 increased compared to the corresponding period of the prior year, primarily due to favorable changes in working capital, partially offset by lower cash provided by earnings.
Investing activities.
Net cash used in investing activities for the six months ended June 30, 2025 was $33.6 million compared to a use of cash of $85.2 million for the corresponding period of the prior year. This change was primarily due to a reduction in capital expenditures and proceeds received from the sale of the MSP Business. Refer to
Note 16: Disposals
for additional information. For fiscal year 2025, we anticipate capital expenditures of approximately $150.0 million, which we expect to fund with cash on hand.
Financing activities
. Net cash used in financing activities for the six months ended June 30, 2025 was 160.8 million compared to cash provided by financing activities of 365.1 million in the corresponding period of the prior year, primarily due to the issuance of the $500.0 million aggregate principal amount of 6.625% senior notes due 2032, partially offset by an increase in the amount of cash paid to repurchase ordinary shares in the current period and the payment of $79.4 million to repurchase the remaining equity interest in a joint venture in the prior year. Refer to
Note 12: Shareholders' Equity
for additional information.
Indebtedness and Liquidity
As of June 30, 2025, we had $3.2 billion in gross indebtedness, which includes finance lease obligations and excludes debt discounts, premiums, and deferred financing costs.
Capital Resources
Sources of liquidity
Our sources of liquidity include cash on hand, cash flows from operations, and available capacity under the Revolving Credit Facility. As of June 30, 2025, we had $745.8 million available under the Revolving Credit Facility, net of $4.2 million of obligations in respect of outstanding letters of credit issued thereunder. Outstanding letters of credit are issued primarily for the benefit of certain operating activities. As of June 30, 2025, no amounts had been drawn against these outstanding letters of credit. This Revolving Credit Facility includes an accordion feature under which maximum borrowings may be increased under certain circumstances.
We believe, based on our current level of operations and taking into consideration the restrictions and covenants included in the Credit Agreement, Revolving Credit Facility, and Senior Notes Indentures, that the sources of liquidity described above will be sufficient to fund our operations, capital expenditures, dividend payments, ordinary share repurchases, and debt service for at least the next twelve months. However, we cannot make assurances that our business will generate sufficient cash flows from operations or that future borrowings will be available to us in an amount sufficient to enable us to pay our indebtedness or to fund our other liquidity needs. Further, our highly-leveraged nature may limit our ability to procure additional financing in the future.
Our ability to raise additional financing, and our borrowing costs, may be impacted by short and long term debt ratings assigned by independent rating agencies, which are based, in significant part, on our performance as measured by certain credit metrics such as interest coverage and leverage ratios. As of July 17, 2025, Moody’s Investors Service’s corporate credit rating for STBV was Ba2 with a stable outlook, and Standard & Poor’s corporate credit rating for STBV was BB+ with a stable outlook. Any future downgrades to STBV's credit ratings may increase our future borrowing costs but will not reduce availability under the Credit Agreement.
Restrictions and Covenants
The Credit Agreement provides that if our senior secured net leverage ratio exceeds a specified level, we are required to use a portion of our excess cash flow, as defined in the Credit Agreement, generated by operating, investing, or financing activities to prepay some or all of the outstanding borrowings under the Senior Secured Credit Facilities. The Credit Agreement also requires mandatory prepayments of the outstanding borrowings under the Senior Secured Credit Facilities upon certain asset dispositions and casualty events, in each case subject to certain reinvestment rights, and upon the incurrence of certain indebtedness (excluding any permitted indebtedness). These provisions were not triggered during the six months ended June 30, 2025.
The Credit Agreement and the Senior Notes Indentures contain restrictions and covenants that limit the ability of our wholly-owned subsidiary, STBV, and certain of its subsidiaries to, among other things, incur subsequent indebtedness, sell assets, pay dividends, and make other restricted payments. For a full discussion of these restrictions and covenants, refer to
Part II, Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations—Capital Resources
included in our 2024 Annual Report. These restrictions and covenants, which are subject to important exceptions and qualifications set forth in the Credit Agreement and Senior Notes Indentures, were taken into consideration when we established our share repurchase programs and will be evaluated periodically with respect to future potential funding of those programs. As of June 30, 2025, we believe we were in compliance with all covenants and default provisions under our credit arrangements.
Share repurchase programs
From time to time, our Board of Directors has authorized various share repurchase programs, which may be modified or terminated by our Board at any time. We currently have authorization for the September 2023 Program, under which approximately $282.4 million remained available as of June 30, 2025. In the six months ended June 30, 2025, and 2024, we repurchased 4.2 million and 0.3 million ordinary shares under the September 2023 Program.
In the six months ended June 30, 2025 and 2024, we paid aggregate cash dividends of $35.5 million and $36.1 million, respectively. In July 2025, we announced that our Board of Directors approved a quarterly dividend of $0.12 per share, payable in August 2025 to shareholders of record as of August 13, 2025.
Critical Accounting Policies and Estimates
For a discussion of the critical accounting policies that require the use of significant judgments and estimates by management, refer to
Part II, Item 7: Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates
included in our 2024 Annual Report. The preparation of consolidated financial statements in accordance with U.S. GAAP requires us to exercise judgment in the process of applying our accounting policies. It also requires that we make estimates and assumptions about future events that affect the amounts reported in the consolidated financial statements and accompanying notes. No material changes to our critical accounting policies and estimates, as previously disclosed, have occurred during the first six months of 2025.
Item 3.
Quantitative and Qualitative Disclosures About Market Risk.
No significant changes to our market risk have occurred since December 31, 2024. For a discussion of market risks affecting us, refer to
Part II, Item 7A: Quantitative and Qualitative Disclosures About Market Risk
included in our 2024 Annual Report.
Item 4.
Controls and Procedures.
The required certifications of our Chief Executive Officer, Chief Financial Officer, and Chief Accounting Officer are included as exhibits to this Quarterly Report on Form 10-Q. The disclosures set forth in this Item 4 contain information concerning the evaluation of our disclosure controls and procedures and changes in internal control over financial reporting referred to in these certifications. These certifications should be read in conjunction with this Item 4 for a more complete understanding of the matters covered by the certifications.
Evaluation of Disclosure Controls and Procedures
With the participation of our Chief Executive Officer, Chief Financial Officer, and Chief Accounting Officer, we have evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2025. The term "disclosure controls and procedures," as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the United States Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Based on the evaluation of our disclosure controls and procedures as of June 30, 2025, our Chief Executive Officer, Chief Financial Officer, and Chief Accounting Officer concluded that, as of such date, our disclosure controls and procedures were not effective at the reasonable assurance level because of the existence of material weaknesses as described below. As of December 31, 2024, the Company identified material weaknesses in maintaining an appropriate internal control environment. The Company did not specify objectives with sufficient clarity to enable an appropriate level of risk assessment and monitoring. Additionally, the Company's control activities did not adequately and consistently establish policies, procedures, information protocols and communications to design and operate effective controls, due in part, to a lack of appropriate accounting personnel, impacting areas such as inventory and account reconciliation processes in our Americas Accounting and Shared Services teams located in Mexico.
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company's annual or interim consolidated financial statements will not be prevented or detected on a timely basis.
Although these material weaknesses did not result in a material misstatement to our audited consolidated financial statements for the year ended December 31, 2024, they have been identified as material weaknesses because there is a possibility that they could lead to a material misstatement of account balances or disclosures.
Changes in Internal Control over Financial Reporting
No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the three months ended June 30, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Material Weakness Remediation Plan
We have devoted a significant amount of time and resources towards remediation of the material weaknesses. We will continue to execute on our remediation plan until the material weaknesses are remediated. Actions taken to date, and expected to be taken, include the following:
•
Completion of an internal organizational assessment to identify gaps in knowledge and staffing levels and consider potential reorganization of our teams.
•
Hiring of additional accounting and IT personnel, including a new Chief Accounting Officer in May 2024, with the appropriate level of knowledge, training, and experience to improve our internal control over financial reporting and IT capabilities. We continue to recruit for additional resources.
•
Engaged a third party to assist in development and formalization of a risk assessment process across the organization to identify risks and design new controls or enhance existing controls responsive to such risks to ensure timely and accurate financial reporting based on criteria established in the COSO framework. We are in various stages of this risk assessment process and control development process, including assessing and documenting control gaps and remediating existing control gaps.
•
Implemented a global system to enhance our account reconciliation process, increase monitoring capabilities, and improve our consistency.
•
Assessed the specific training needs for newly hired and existing personnel and developed and delivered training programs designed to enhance our internal controls over financial reporting.
•
Enhanced the procedures regarding our annual physical inventory counts, including employee training in performing annual physical counts and clarification of instructions as to the process for recording adjustments to inventory as a result of physical counts. We have completed physical inventories at all of our locations.
We are committed to the remediation of these material weaknesses and expect to successfully implement enhanced control processes. However, as we continue to evaluate and work to improve our internal control over financial reporting, we may determine that additional measures to address control deficiencies or modifications to the remediation plan are necessary.
Inherent Limitations on Effectiveness of Controls
There are inherent limitations to the effectiveness of any system of internal control over financial reporting. Accordingly, even an effective system of internal control over financial reporting can only provide reasonable assurance with respect to financial statement preparation and presentation in accordance with United States generally accepted accounting principles. Our internal controls over financial reporting are subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the soundness of our systems, the possibility of human error, and the risk of fraud. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may be inadequate because of changes in conditions and the risk that the degree of compliance with policies or procedures may deteriorate over time.
We are regularly involved in a number of claims and litigation matters that arise in the ordinary course of business. Although it is not feasible to predict the outcome of these matters, based upon our experience and current information known to us, we do not expect the outcome of these matters, either individually or in the aggregate, to have a material adverse effect on our results of operations, financial condition, and/or cash flows.
Item 1A.
Risk Factors.
Information regarding risk factors appears in
Part I, Item 1A: Risk Factors
, included in our 2024 Annual Report. There have been no material changes to the risk factors disclosed therein.
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
Issuer Purchases of Equity Securities
Period
Total Number of Shares Purchased (in shares)
(1)
Weighted-Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plan or Programs
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plan or Programs
(in millions)
April 1 through April 30, 2025
135,637
$
24.23
—
$
302.5
May 1 through May 31, 2025
246
$
21.37
—
$
302.5
June 1 through June 30, 2025
707,143
$
28.65
701,232
$
282.4
Quarter total
843,026
$
27.94
701,232
$
282.4
___________________________________
(1)
The total number of ordinary shares purchased includes ordinary shares that were withheld upon the vesting of restricted securities to cover payment of employee withholding tax. These withholdings took place outside of a publicly announced repurchase plan. There were 135,637, 246, and 5,911 ordinary shares withheld in April 2025, May 2025, and June 2025, respectively, representing a total aggregate fair value of $3.5 million based on the closing price of our ordinary shares on the date of withholdings.
Item 3.
Defaults Upon Senior Securities.
None.
Item 5. Other Information
On
June 9, 2025
,
Lynne Caljouw
,
Executive Vice President and Chief Human Resources Officer
, an officer for purposes of Section 16 of the Exchange Act,
entered
into a "Rule 10b5-1
trading arrangement
" as such term is defined in Item 408(a) of Regulation S-K. This arrangement was entered into during an open trading window and provides for the potential sale of up to
28,688
ordinary shares contingent on attainment of certain price per share of our common stock. The earliest sell date is September 8, 2025 and the plan will terminate upon the earlier of
June 30, 2026
or the date all ordinary shares under the plan are sold. In addition, Ms. Caljouw may terminate the plan at any time.
Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: July 29, 2025
SENSATA TECHNOLOGIES HOLDING PLC
/s/ Stephan von Schuckmann
(Stephan von Schuckmann)
Chief Executive Officer
(Principal Executive Officer)
/s/ Andrew Lynch
(Andrew Lynch)
Executive Vice President and Chief Financial Officer
Customers and Suppliers of Sensata Technologies Holding plc
Beta
No Customers Found
No Suppliers Found
Bonds of Sensata Technologies Holding plc
Price Graph
Price
Yield
Insider Ownership of Sensata Technologies Holding plc
company Beta
Owner
Position
Direct Shares
Indirect Shares
AI Insights
Summary Financials of Sensata Technologies Holding plc
Beta
(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)